June 22, 2024 12:27 am
Search
Close this search box.

One year after FDA approves over-the-counter birth control pill, advocates push for more access

It’s been one year since the U.S. Food and Drug Administration approved the first over-the-counter birth control pill, Opill, and less than two months since it hit store shelves. Advocates celebrate its availability, but say access is still lacking in terms of cost barriers and insurance coverage.

Opill, the first over-the-counter birth control pill, will be on shelves soon − here are some key things to know

The Food and Drug Administration’s 2023 approval of the first over-the-counter birth control pill, called Opill, broadened the options for people seeking to prevent pregnancy. On March 4, 2024, the pill’s manufacturer, Perrigo Company, announced that it has started shipping Opill and that consumers can expect to see it on shelves by the end of the month.

Patients See First Savings From Biden’s Drug Price Push, as Pharma Lines Up Its Lawyers

President Joe Biden’s battle against high drug prices is mostly embodied in the IRA, as the law is known — a grab bag of measures intended to give Medicare patients immediate relief and, in the long term, to impose government controls on what pharmaceutical companies charge for their products. The law represents the most significant overhaul for the U.S. drug marketplace in decades.